FABIFLU 200mg Tablet 34's

Viral infections Rx required

Best Price*  ₹ 1,033.60
MRP ₹1,292.00
(Inclusive of all taxes) *34 Tablet(s) in a Strip * Mkt: Glenmark Pharmaceuticals Ltd * Country of Origin: India * Delivery charges if applicable will be applied at checkout

Check Availability & Expiry

PINCODE:


INTRODUCTION

FABIFLU 200MG contains Favipiravir which belongs to a group of medicines called antiviral agents. It is indicated for the treatment of patients with mild to moderate COVID-19 disease. This medicine does not treat bacterial infections. Coronavirus disease (Covid-19) is a highly infectious disease which caused by a strain of a virus called coronavirus. The common symptoms are fever, cough, loss of taste or smell, breathing difficulty, nasal congestion and diarrhea.

Always take this FABIFLU 200MG exactly as directed by your doctor. Before taking this medicine, tell your physician if you have liver, kidney or heart problems. It is not recommended for pregnant women and breastfeeding mothers. It is not suitable for use in children. The common side effects are increase in blood uric acid levels, reduction in white blood cells count, diarrhoea and increase in liver enzymes.

USES OF FABIFLU 200MG

  • Treats mild to moderate coronavirus 2 (SARS-CoV-2) infection in adults

HOW FABIFLU 200MG WORKS

RNA polymerase is the enzyme which helps SARS-CoV-2 virus to make new RNA, so it is essential for the virus to make more copies of itself in the body. Favipiravir selectively targets this enzyme, to inhibit the replication of the COVID-19 causing virus in the body.

DIRECTIONS FOR USE

Always take this FABIFLU 200MG exactly as your doctor has told you. Swallow as whole and do not crush or chew. Do not exceed the recommended dose.

SIDE EFFECTS OF FABIFLU 200MG

COMMON

  • increase in blood uric acid levels
  • diarrhoea
  • reduction in white blood cells count
  • increase in liver enzymes

HOW TO MANAGE SIDE EFFECTS

Diarrhoea:

Drink plenty of fluids to avoid dehydration. ORS can be used to prevent dehydration.

WARNING & PRECAUTIONS

PREGNANCY

FABIFLU 200MG is not recommended for use in pregnant women unless necessary. Consult your doctor for advice.

BREASTFEEDING

FABIFLU 200MG is not recommended for use in breastfeeding women unless necessary. Consult your doctor for advice.

DRIVING AND USING MACHINES

Do not drive or operate any machines if you have abnormal behaviour or impaired concentration while taking this FABIFLU 200MG.

KIDNEY

FABIFLU 200MG is not recommended in patients with active kidney diseases. Consult your doctor for advice.

LIVER

FABIFLU 200MG is not recommended in patients with active liver diseases. Consult your doctor for advice.

ALLERGY

Do not take if you are allergic (hypersensitive) to Favipiravir.

OTHERS

Tell your doctor before taking this medicine if you have or had:

  • history of gout or hyperuricaemia
  • any other medical condition

INTERACTIONS

Tell your doctor if you are taking,

  • pyrazinamide (treats tuberculosis)
  • repaglinide (treats high blood sugar)
  • theophylline (treats asthma or breathing problems)
  • famciclovir, oseltamivir (treats antiviral infection)
  • sulindac (relieves pain)

SYNOPSIS

Drug :   Favipiravir
Pharmacological Category :   Antiviral agents
Therapeutic Indication :   Mild to moderate COVID-19 disease
Dosage Forms :   Tablet

MORE INFORMATION

Store at room temperature and keep out of reach of children.

FAQs ABOUT FABIFLU 200MG

Can FABIFLU 200MG be used during pregnant or breastfeeding?

No, this medicine should not be used for treating Covid-19 infection in pregnant or breastfeeding women.  If you are planning a baby, pregnant or breastfeeding, consult your doctor if you are tested positive for Covid-19 or even if you are suspected of Covid-19 infection.

How does FABIFLU 200MG work?

It inhibits replication (a process by which this virus multiplies) of the Covid-19 virus and stops the further spread of the infection.

For how long and in what dose should FABIFLU 200MG be taken?

It must be taken in the dose and duration advised by the doctor.

REFERENCES

1. Umang Agrawal, Reyma Raju and Zarir F. Udwadia. Favipiravir: A new and emerging antiviral option in COVID-19. Oct, 2020. [Accessed on May 11, 2021] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467067/

2. Shashank Joshi., Jalil Parkar, Abdul Ansari, Mangesh Tiwaskar, Saiprasad Patil and Hanmant Barkate. Role of Favipiravir in the treatment of COVID-19. October 29, 2020. [Accessed on May 11, 2021] https://www.ijidonline.com/article/S1201-9712(20)32273-6/fulltext

3. Cipla Ltd. July 23, 2020. [Revised on Nov 27, 2020] [Accessed on May 11, 2021] https://www.ciplamed.com/printpdf/47598

4. Glenmark Pharmaceuticals Limited. June, 2020. [Accessed on May 11, 2021] https://www.glenmarkpharma.com/sites/default/files/Glenmark-FabiFlu-Press-Brief.pdf

USEFUL DIAGNOSTIC TESTS

  • RT PCR test

PRODUCT DETAILS

    Net Qty
    1
    Item Weight
    50
    Ingredient
    Favipiravir 200 MG
    Hsn Code
    30049099
ALTERNATE BRANDS
CIPVIR 200mg Tablet 10's
Prescription Viral infections Rx required
Out of stock
Rs.450.00
AVIGAN 200mg Tablet 122's
Prescription Viral infections Rx required
Out of stock
Rs.12,078.00
DISCLAIMER

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

FABIFLU 200mg Tablet 34's

FABIFLU 200mg Tablet 34's Mkt: Glenmark Pharmaceuticals Ltd

M.R.P.: Rs.1,292.00
Copyright© 2021. All Rights Reserved.